Psychiatric Adverse Effects of Levetiracetam in Malignant Glioma Populations; a Retrospective Cohort Study

Objective: Levetiracetam is commonly used in malignant glioma populations because of its efficacy, limited drug-drug interactions and adverse effects. Although, there has been growing evidence of adverse neuropsychiatric side effects from levetiracetam; however, such evidence in malignant brain tumo...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Paul Thisayakorn, Isabel Schuermeyer
Format: article
Langue:EN
Publié: Prince of Songkla University 2021
Sujets:
R
Accès en ligne:https://doaj.org/article/2719ee7b09eb47e882fdd9822721fa80
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!